Next Financial Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$295K Sell
1,707
-877
-34% -$133K 0.02% 737
2021
Q3
$376K Sell
2,584
-570
-18% -$83.4K 0.03% 588
2021
Q2
$416K Sell
3,154
-1,074
-25% -$141K 0.03% 544
2021
Q1
$543K Buy
4,228
+2,501
+145% +$308K 0.05% 394
2020
Q4
$206K Sell
1,727
-422
-20% -$51.4K 0.02% 703
2020
Q3
$246K Buy
2,149
+333
+18% +$39.3K 0.03% 552
2020
Q2
$207K Buy
1,816
+1,232
+211% +$131K 0.02% 529
2020
Q1
$47K Buy
584
+474
+431% +$49.1K 0.01% 1005
2019
Q4
$12K Buy
110
+21
+24% +$2.19K ﹤0.01% 1701
2019
Q3
$10K Sell
89
-391
-81% -$40.1K ﹤0.01% 1698
2019
Q2
$49K Buy
480
+300
+167% +$28.8K 0.01% 1168
2019
Q1
$16K Hold
180
﹤0.01% 1009
2018
Q4
$15K Sell
180
-86
-32% -$8.06K ﹤0.01% 1196
2018
Q3
$29K Buy
+266
New +$29.2K 0.01% 667
2017
Q4
Sell
-266
Closed -$24K 510
2017
Q3
$24K Sell
266
-100
-27% -$10.6K 0.01% 910
2017
Q2
$41K Hold
366
0.01% 840
2017
Q1
$39K Sell
366
-409
-53% -$39K 0.01% 803
2016
Q4
$71K Hold
775
0.01% 814
2016
Q3
$66K Buy
775
+409
+112% +$34.3K 0.01% 820
2016
Q2
$29K Buy
366
+86
+31% +$6.55K 0.01% 820
2016
Q1
$20K Hold
280
0.01% 926
2015
Q4
$19K Hold
280
0.01% 937
2015
Q3
$17K Buy
280
+35
+14% +$2.45K 0.01% 1011
2015
Q2
$17K Hold
245
0.01% 1057
2015
Q1
$18K Hold
245
0.01% 1027
2014
Q4
$16K Sell
245
-421
-63% -$26.6K 0.01% 1055
2014
Q3
$40K Buy
+666
New +$41K 0.01% 1059

Other funds holding DGX

Next Financial Group's DGX Position: Q4 2021 in Review

Next Financial Group reduced its Quest Diagnostics (DGX) stake by 34% in Q4 2021, selling an estimated $133K and leaving 1,707 shares worth $295K. The position accounts for 0.02% of the portfolio, ranked #737.

Next Financial Group first reported a position in DGX in Q3 2014 and has held it in 27 quarters since. The position peaked at $543K in Q1 2021. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Next Financial Group held 1,707 shares of Quest Diagnostics worth $295K as of Q4 2021.
  • Next Financial Group sold 877 Quest Diagnostics shares in Q4 2021, an estimated $133K.
  • Quest Diagnostics made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #737 holding.
  • Next Financial Group first reported a position in Quest Diagnostics in Q3 2014 and has held it in 27 quarters since.
  • Next Financial Group's Quest Diagnostics position peaked at $543K in Q1 2021.
  • 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.